Enhanced Prevalence of Plasmatic Soluble MHC Class I Chain-Related Molecule in Vascular Pregnancy Diseases

Table 2

Frequency of sMIC detection and plasma levels in the study population.

	Frequency of sMIC positive plasma; number; (proportion %)	Comparison of sMIC frequency in reference to control normal pregnancy group	Median sMIC plasma levels in positive samples (ng/mL) [25–75 interquartile range]
Normal pregnancies	1 (1.6%)	—	0.5
Vascular pregnancy diseases	26 (32%)		2.2 [1.15–11.47]
Preeclampsia	9 (22.5%)		7.5 [1.37–32.69]
Vascular IUGR	9 (39%)		1.63 [0.86–5.2]
IUFD	8 (44%)		2.18 [0.86–7.58]
Nonvascular IUGR	1 (4%)	ns	1.63